Literature DB >> 19586613

p38alpha- and DYRK1A-dependent phosphorylation of caspase-9 at an inhibitory site in response to hyperosmotic stress.

Anne Seifert1, Paul R Clarke.   

Abstract

The cysteine aspartyl protease caspase-9 is a critical component of the intrinsic apoptotic pathway. Activation of caspase-9 is inhibited by phosphorylation at Thr125, which is catalysed by the mitogen-activated protein kinases (MAPKs) ERK1/2 in response to growth factors, by the cyclin-dependent protein kinase CDK1-cyclin B1 during mitosis, and at a basal level by the dual-specificity tyrosine-phosphorylation regulated protein kinase DYRK1A. Here we show that inhibitory phosphorylation of caspase-9 at Thr125 is induced in mammalian cells by hyperosmotic stress. This response does not require ERK1/2 or ERK5, but it is diminished by ablation of DYRK1A expression by siRNA or chemical inhibition of DYRK1A by harmine. Phosphorylation of Thr125 in response to hyperosmotic stress is also reduced by chemical inhibition of p38 MAPK and is abolished in p38 alpha(-/-) mouse embryonic fibroblasts. These results show that both DYRK1A and p38 alpha play roles in the inhibitory phosphorylation of caspase-9 following hyperosmotic stress and suggest a functional interaction between these protein kinases. Phosphorylation of caspase-9 at Thr125 may restrain apoptosis during the acute response to hyperosmotic stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586613     DOI: 10.1016/j.cellsig.2009.06.009

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  19 in total

Review 1.  Regulation of the Apaf-1-caspase-9 apoptosome.

Authors:  Shawn B Bratton; Guy S Salvesen
Journal:  J Cell Sci       Date:  2010-10-01       Impact factor: 5.285

Review 2.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

Review 3.  Cellular mechanisms controlling caspase activation and function.

Authors:  Amanda B Parrish; Christopher D Freel; Sally Kornbluth
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-06-01       Impact factor: 10.005

4.  Rsk-mediated phosphorylation and 14-3-3ɛ binding of Apaf-1 suppresses cytochrome c-induced apoptosis.

Authors:  Jiyeon Kim; Amanda B Parrish; Manabu Kurokawa; Kenkyo Matsuura; Christopher D Freel; Joshua L Andersen; Carrie E Johnson; Sally Kornbluth
Journal:  EMBO J       Date:  2012-01-13       Impact factor: 11.598

Review 5.  p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.

Authors:  Valentina Grossi; Alessia Peserico; Tugsan Tezil; Cristiano Simone
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 6.  Evading apoptosis in cancer.

Authors:  Kaleigh Fernald; Manabu Kurokawa
Journal:  Trends Cell Biol       Date:  2013-08-16       Impact factor: 20.808

7.  A Crosstalk Between Dual-Specific Phosphatases and Dual-Specific Protein Kinases Can Be A Potential Therapeutic Target for Anti-cancer Therapy.

Authors:  Basak Celtikci
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  MiR-1246: a new link of the p53 family with cancer and Down syndrome.

Authors:  Jun-Ming Liao; Xiang Zhou; Yu Zhang; Hua Lu
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

Review 9.  DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis.

Authors:  Amina Jamal Laham; Maha Saber-Ayad; Raafat El-Awady
Journal:  Cell Mol Life Sci       Date:  2020-09-01       Impact factor: 9.261

Review 10.  Caspases and kinases in a death grip.

Authors:  Manabu Kurokawa; Sally Kornbluth
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.